Gasporin Tablet
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Ahn-Gook Pharmaceutical Co., Ltd.
MFDS item code 201500081 · Approved 2015.01.08
This product's status changed to Expired on 2025.01.08. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (e.g., ulcers and gastroesophageal reflux disease); prevention of Mendelson syndrome
This medication is used for gastrointestinal diseases such as ulcers of the stomach and duodenum, gastritis, and gastroesophageal reflux disease. It is also effective for disorders associated with excessive gastric acid secretion like Zollinger-Ellison syndrome. It is administered prior to anesthesia to prevent Mendelson's syndrome and helps treat ulcers after surgery. This medication is also used to treat gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). Thus, it is effective in improving various gastrointestinal-related disorders.
Usually, take 2 tablets by mouth twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Take 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, in patients with duodenal ulcers, a higher healing rate may be achieved by taking 4 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) or for prevention of gastric and duodenal ulcers during long-term NSAID use. Ulcers caused by NSAID use generally heal within 4 weeks, and other ulcers generally heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, take 2 tablets twice daily or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets 3 times daily, and increase the dose if necessary. For severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and give 2 tablets twice daily. 5) Premedication (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets on the night before surgery.
This medication should not be used by patients receiving dialysis or those allergic to this drug or its components. It is also advisable to avoid use in patients with a history of acute porphyria, poor kidney function, those who have undergone upper gastrointestinal surgery, pregnant women or those who may become pregnant, premature or newborn infants, and patients on potassium-restricted diets. Patients with impaired liver function or with a history of drug allergies, elderly patients, those with past kidney issues, and those taking NSAIDs should use this drug cautiously. Notably, this medication may mask symptoms of gastric cancer, so patients with gastric ulcers or middle-aged individuals recently experiencing new or changed indigestion symptoms should have malignant status checked before treatment. Patients with gastric or duodenal ulcers due to Helicobacter pylori infection require bacterial eradication treatment. Special precautions are needed for critically ill patients or patients with hypophosphatemia and those with swallowing difficulties while using this medication. This medication can rarely cause allergic reactions such as anaphylactic shock, skin rash, hives, angioedema, fever, bronchospasm, so use should be discontinued immediately if symptoms appear. Blood-related abnormalities like leukopenia, thrombocytopenia, and liver function impairment may occur; if such symptoms arise, stop administration immediately and consult a physician. Neurological symptoms such as heart arrhythmias, gastrointestinal symptoms, dizziness, drowsiness, mental confusion, depression, and hallucinations can also occur rarely, so caution is advised. Side effects such as gynecomastia, erectile dysfunction, arthralgia, myalgia, skin rash, and hair loss have been reported. This medication should not be used for long periods, and treatment progress should be closely monitored while using the minimum effective dose. Elderly patients or those with chronic lung disease or diabetes may face an increased risk of pneumonia, so caution is advised. If dizziness or drowsiness occurs, avoid driving or operating dangerous machinery. This medication may interact with other drugs, so inform medical personnel of any medications being taken, and ensure to separate doses from certain medications. Pregnant or breastfeeding women should avoid this medication, and it is advised not to use it in children as safety and efficacy have not been established. In case of overdose, emergency treatment such as vomiting or gastric lavage may be necessary, and blood dialysis may be required if needed. This drug reduces gastric acid secretion and can promote bacterial growth in the intestines, so ophthalmic examination may be necessary for long-term use.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent air or moisture from entering, and it is important to store it at room temperature between 1°C and 30°C. Storing it this way will help maintain the drug's effectiveness and prevent deterioration.
Green round film-coated tablet
30 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Ahn-Gook Pharmaceutical Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.